Details of the Drug

General Information of Drug (ID: DM20CIM)

Drug Name
RNF43-721
Synonyms RNF43-721/Montanide ISA51; Peptide vaccine (subcutaneous, colorectal cancer), Tokyo Women's Medical College
Indication
Disease Entry ICD 11 Status REF
Colorectal cancer 2B91.Z Phase 2 [1]
Cross-matching ID
TTD ID
D01EXL

Molecular Interaction Atlas of This Drug


Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
RING finger protein 43 (RNF43) TTD91BL RNF43_HUMAN Modulator [1]
Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This Drug

Molecular Expression Atlas of This Drug

The Studied Disease Colorectal cancer
ICD Disease Classification 2B91.Z
Molecule Name Molecule Type Gene Name p-value Fold-Change Z-score
RING finger protein 43 (RNF43) DTT RNF43 2.79E-04 1.13 3.02
Molecular Expression Atlas (MEA) Jump to Detail Molecular Expression Atlas of This Drug

References

1 Phase I clinical trial of a novel peptide vaccine in combination with UFT/LV for metastatic colorectal cancer. Exp Ther Med. 2011 Jan-Feb; 2(1): 73-79.